Loading…

Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice

A Mediterranean diet rich in olive oil has profound influence on health outcomes including metabolic syndrome. However, the active compound and detailed mechanisms still remain unclear. Hydroxytyrosol (HT), a major polyphenolic compound in virgin olive oil, has received increased attention for its a...

Full description

Saved in:
Bibliographic Details
Published in:Free radical biology & medicine 2014-02, Vol.67, p.396-407
Main Authors: Cao, Ke, Xu, Jie, Zou, Xuan, Li, Yuan, Chen, Cong, Zheng, Adi, Li, Hao, Li, Hua, Szeto, Ignatius Man-Yau, Shi, Yujie, Long, Jiangang, Liu, Jiankang, Feng, Zhihui
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3
cites cdi_FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3
container_end_page 407
container_issue
container_start_page 396
container_title Free radical biology & medicine
container_volume 67
creator Cao, Ke
Xu, Jie
Zou, Xuan
Li, Yuan
Chen, Cong
Zheng, Adi
Li, Hao
Li, Hua
Szeto, Ignatius Man-Yau
Shi, Yujie
Long, Jiangang
Liu, Jiankang
Feng, Zhihui
description A Mediterranean diet rich in olive oil has profound influence on health outcomes including metabolic syndrome. However, the active compound and detailed mechanisms still remain unclear. Hydroxytyrosol (HT), a major polyphenolic compound in virgin olive oil, has received increased attention for its antioxidative activity and regulation of mitochondrial function. Here, we investigated whether HT is the active compound in olive oil exerting a protective effect against metabolic syndrome. In this study, we show that HT could prevent high-fat-diet (HFD)-induced obesity, hyperglycemia, hyperlipidemia, and insulin resistance in C57BL/6J mice after 17 weeks supplementation. Within liver and skeletal muscle tissues, HT could decrease HFD-induced lipid deposits through inhibition of the SREBP-1c/FAS pathway, ameliorate HFD-induced oxidative stress by enhancing antioxidant enzyme activities, normalize expression of mitochondrial complex subunits and mitochondrial fission marker Drp1, and eventually inhibit apoptosis activation. Moreover, in muscle tissue, the levels of mitochondrial carbonyl protein were decreased and mitochondrial complex activities were significantly improved by HT supplementation. In db/db mice, HT significantly decreased fasting glucose, similar to metformin. Notably, HT decreased serum lipid, at which metformin failed. Also, HT was more effective at decreasing the oxidation levels of lipids and proteins in both liver and muscle tissue. Similar to the results in the HFD model, HT decreased muscle mitochondrial carbonyl protein levels and improved mitochondrial complex activities in db/db mice. Our study links the olive oil component HT to diabetes and metabolic disease through changes that are not limited to decreases in oxidative stress, suggesting a potential pharmaceutical or clinical use of HT in metabolic syndrome treatment. •High-fat-diet (HFD)-induced metabolic syndrome was prevented by hydroxytyrosol.•Hydroxytyrosol (HT) could inhibit the SREBP-1c/FAS pathway in mouse liver and muscle.•HFD-induced oxidative stress and mitochondrial abnormalities were eliminated by HT.•HT improved lipid and glucose metabolism in db/db mice.•HT reduced oxidative damage and improved mitochondrial activity in db/db mice.
doi_str_mv 10.1016/j.freeradbiomed.2013.11.029
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1687662343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0891584913015347</els_id><sourcerecordid>1687662343</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3</originalsourceid><addsrcrecordid>eNqNkctu1DAUQC0EokPbX0CW2LBJsGOPH2KFqtIiVWIDa8uxb4RHiT3YTkX-Ho-mXXQFq7u45z4PQh8o6Smh4tOhnzJAtn4MaQHfD4SyntKeDPoV2lElWcf3WrxGO6I07faK6wv0rpQDIYTvmXqLLgbOqGCS7tDxfvM5_dnqllNJMz5meIRYC_YBaheiXx14vEC1Y5qDw2WLjV8A2-ixrRXiaisUvISa3K_UksHO2I4x5cXOoYaWCxGnEQo0yMEVejPZucD1U7xEP7_e_ri57x6-3327-fLQOU5F7QQQqtWkJGm7OjpIJ4XgkqvR8sEzwvnUjpFMaksGMoJuZ0qlNAg2EjIAu0Qfz32POf1eoVSzhOJgnm2EtBZDhWodB8bZv1GuNd3ztkpDP59R195VMkzmmMNi82YoMSc75mBe2DEnO4ZS0-y06vdPg9bxlHuufdbRgNszAO0zjwGyKS5AbApCBleNT-G_Bv0FEi-pRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1499154702</pqid></control><display><type>article</type><title>Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice</title><source>ScienceDirect Freedom Collection</source><creator>Cao, Ke ; Xu, Jie ; Zou, Xuan ; Li, Yuan ; Chen, Cong ; Zheng, Adi ; Li, Hao ; Li, Hua ; Szeto, Ignatius Man-Yau ; Shi, Yujie ; Long, Jiangang ; Liu, Jiankang ; Feng, Zhihui</creator><creatorcontrib>Cao, Ke ; Xu, Jie ; Zou, Xuan ; Li, Yuan ; Chen, Cong ; Zheng, Adi ; Li, Hao ; Li, Hua ; Szeto, Ignatius Man-Yau ; Shi, Yujie ; Long, Jiangang ; Liu, Jiankang ; Feng, Zhihui</creatorcontrib><description>A Mediterranean diet rich in olive oil has profound influence on health outcomes including metabolic syndrome. However, the active compound and detailed mechanisms still remain unclear. Hydroxytyrosol (HT), a major polyphenolic compound in virgin olive oil, has received increased attention for its antioxidative activity and regulation of mitochondrial function. Here, we investigated whether HT is the active compound in olive oil exerting a protective effect against metabolic syndrome. In this study, we show that HT could prevent high-fat-diet (HFD)-induced obesity, hyperglycemia, hyperlipidemia, and insulin resistance in C57BL/6J mice after 17 weeks supplementation. Within liver and skeletal muscle tissues, HT could decrease HFD-induced lipid deposits through inhibition of the SREBP-1c/FAS pathway, ameliorate HFD-induced oxidative stress by enhancing antioxidant enzyme activities, normalize expression of mitochondrial complex subunits and mitochondrial fission marker Drp1, and eventually inhibit apoptosis activation. Moreover, in muscle tissue, the levels of mitochondrial carbonyl protein were decreased and mitochondrial complex activities were significantly improved by HT supplementation. In db/db mice, HT significantly decreased fasting glucose, similar to metformin. Notably, HT decreased serum lipid, at which metformin failed. Also, HT was more effective at decreasing the oxidation levels of lipids and proteins in both liver and muscle tissue. Similar to the results in the HFD model, HT decreased muscle mitochondrial carbonyl protein levels and improved mitochondrial complex activities in db/db mice. Our study links the olive oil component HT to diabetes and metabolic disease through changes that are not limited to decreases in oxidative stress, suggesting a potential pharmaceutical or clinical use of HT in metabolic syndrome treatment. •High-fat-diet (HFD)-induced metabolic syndrome was prevented by hydroxytyrosol.•Hydroxytyrosol (HT) could inhibit the SREBP-1c/FAS pathway in mouse liver and muscle.•HFD-induced oxidative stress and mitochondrial abnormalities were eliminated by HT.•HT improved lipid and glucose metabolism in db/db mice.•HT reduced oxidative damage and improved mitochondrial activity in db/db mice.</description><identifier>ISSN: 0891-5849</identifier><identifier>EISSN: 1873-4596</identifier><identifier>DOI: 10.1016/j.freeradbiomed.2013.11.029</identifier><identifier>PMID: 24316371</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Antioxidants - pharmacology ; Apoptosis ; Blood Glucose - metabolism ; Diet, High-Fat ; Dietary Fats - adverse effects ; Dynamins - genetics ; Dynamins - metabolism ; fas Receptor - genetics ; fas Receptor - metabolism ; Free radicals ; Gene Expression Regulation ; Hydroxytyrosol ; Hyperglycemia - drug therapy ; Hyperglycemia - etiology ; Hyperglycemia - metabolism ; Hyperglycemia - pathology ; Hyperlipidemias - drug therapy ; Hyperlipidemias - etiology ; Hyperlipidemias - metabolism ; Hyperlipidemias - pathology ; Insulin Resistance ; Lipid Metabolism - drug effects ; Male ; Metabolic Syndrome - drug therapy ; Metabolic Syndrome - etiology ; Metabolic Syndrome - metabolism ; Metabolic Syndrome - pathology ; Mice ; Mice, Inbred C57BL ; Mitochondria - drug effects ; Mitochondria - metabolism ; Mitochondria - pathology ; Mitochondrial abnormalities ; Obesity - drug therapy ; Obesity - etiology ; Obesity - metabolism ; Obesity - pathology ; Olea ; Oxidative stress ; Oxidative Stress - drug effects ; Phenylethyl Alcohol - analogs &amp; derivatives ; Phenylethyl Alcohol - pharmacology ; Protein Carbonylation ; Signal Transduction ; Sterol Regulatory Element Binding Protein 1 - genetics ; Sterol Regulatory Element Binding Protein 1 - metabolism</subject><ispartof>Free radical biology &amp; medicine, 2014-02, Vol.67, p.396-407</ispartof><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3</citedby><cites>FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24316371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cao, Ke</creatorcontrib><creatorcontrib>Xu, Jie</creatorcontrib><creatorcontrib>Zou, Xuan</creatorcontrib><creatorcontrib>Li, Yuan</creatorcontrib><creatorcontrib>Chen, Cong</creatorcontrib><creatorcontrib>Zheng, Adi</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>Li, Hua</creatorcontrib><creatorcontrib>Szeto, Ignatius Man-Yau</creatorcontrib><creatorcontrib>Shi, Yujie</creatorcontrib><creatorcontrib>Long, Jiangang</creatorcontrib><creatorcontrib>Liu, Jiankang</creatorcontrib><creatorcontrib>Feng, Zhihui</creatorcontrib><title>Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice</title><title>Free radical biology &amp; medicine</title><addtitle>Free Radic Biol Med</addtitle><description>A Mediterranean diet rich in olive oil has profound influence on health outcomes including metabolic syndrome. However, the active compound and detailed mechanisms still remain unclear. Hydroxytyrosol (HT), a major polyphenolic compound in virgin olive oil, has received increased attention for its antioxidative activity and regulation of mitochondrial function. Here, we investigated whether HT is the active compound in olive oil exerting a protective effect against metabolic syndrome. In this study, we show that HT could prevent high-fat-diet (HFD)-induced obesity, hyperglycemia, hyperlipidemia, and insulin resistance in C57BL/6J mice after 17 weeks supplementation. Within liver and skeletal muscle tissues, HT could decrease HFD-induced lipid deposits through inhibition of the SREBP-1c/FAS pathway, ameliorate HFD-induced oxidative stress by enhancing antioxidant enzyme activities, normalize expression of mitochondrial complex subunits and mitochondrial fission marker Drp1, and eventually inhibit apoptosis activation. Moreover, in muscle tissue, the levels of mitochondrial carbonyl protein were decreased and mitochondrial complex activities were significantly improved by HT supplementation. In db/db mice, HT significantly decreased fasting glucose, similar to metformin. Notably, HT decreased serum lipid, at which metformin failed. Also, HT was more effective at decreasing the oxidation levels of lipids and proteins in both liver and muscle tissue. Similar to the results in the HFD model, HT decreased muscle mitochondrial carbonyl protein levels and improved mitochondrial complex activities in db/db mice. Our study links the olive oil component HT to diabetes and metabolic disease through changes that are not limited to decreases in oxidative stress, suggesting a potential pharmaceutical or clinical use of HT in metabolic syndrome treatment. •High-fat-diet (HFD)-induced metabolic syndrome was prevented by hydroxytyrosol.•Hydroxytyrosol (HT) could inhibit the SREBP-1c/FAS pathway in mouse liver and muscle.•HFD-induced oxidative stress and mitochondrial abnormalities were eliminated by HT.•HT improved lipid and glucose metabolism in db/db mice.•HT reduced oxidative damage and improved mitochondrial activity in db/db mice.</description><subject>Animals</subject><subject>Antioxidants - pharmacology</subject><subject>Apoptosis</subject><subject>Blood Glucose - metabolism</subject><subject>Diet, High-Fat</subject><subject>Dietary Fats - adverse effects</subject><subject>Dynamins - genetics</subject><subject>Dynamins - metabolism</subject><subject>fas Receptor - genetics</subject><subject>fas Receptor - metabolism</subject><subject>Free radicals</subject><subject>Gene Expression Regulation</subject><subject>Hydroxytyrosol</subject><subject>Hyperglycemia - drug therapy</subject><subject>Hyperglycemia - etiology</subject><subject>Hyperglycemia - metabolism</subject><subject>Hyperglycemia - pathology</subject><subject>Hyperlipidemias - drug therapy</subject><subject>Hyperlipidemias - etiology</subject><subject>Hyperlipidemias - metabolism</subject><subject>Hyperlipidemias - pathology</subject><subject>Insulin Resistance</subject><subject>Lipid Metabolism - drug effects</subject><subject>Male</subject><subject>Metabolic Syndrome - drug therapy</subject><subject>Metabolic Syndrome - etiology</subject><subject>Metabolic Syndrome - metabolism</subject><subject>Metabolic Syndrome - pathology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondria - pathology</subject><subject>Mitochondrial abnormalities</subject><subject>Obesity - drug therapy</subject><subject>Obesity - etiology</subject><subject>Obesity - metabolism</subject><subject>Obesity - pathology</subject><subject>Olea</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Phenylethyl Alcohol - analogs &amp; derivatives</subject><subject>Phenylethyl Alcohol - pharmacology</subject><subject>Protein Carbonylation</subject><subject>Signal Transduction</subject><subject>Sterol Regulatory Element Binding Protein 1 - genetics</subject><subject>Sterol Regulatory Element Binding Protein 1 - metabolism</subject><issn>0891-5849</issn><issn>1873-4596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNkctu1DAUQC0EokPbX0CW2LBJsGOPH2KFqtIiVWIDa8uxb4RHiT3YTkX-Ho-mXXQFq7u45z4PQh8o6Smh4tOhnzJAtn4MaQHfD4SyntKeDPoV2lElWcf3WrxGO6I07faK6wv0rpQDIYTvmXqLLgbOqGCS7tDxfvM5_dnqllNJMz5meIRYC_YBaheiXx14vEC1Y5qDw2WLjV8A2-ixrRXiaisUvISa3K_UksHO2I4x5cXOoYaWCxGnEQo0yMEVejPZucD1U7xEP7_e_ri57x6-3327-fLQOU5F7QQQqtWkJGm7OjpIJ4XgkqvR8sEzwvnUjpFMaksGMoJuZ0qlNAg2EjIAu0Qfz32POf1eoVSzhOJgnm2EtBZDhWodB8bZv1GuNd3ztkpDP59R195VMkzmmMNi82YoMSc75mBe2DEnO4ZS0-y06vdPg9bxlHuufdbRgNszAO0zjwGyKS5AbApCBleNT-G_Bv0FEi-pRQ</recordid><startdate>201402</startdate><enddate>201402</enddate><creator>Cao, Ke</creator><creator>Xu, Jie</creator><creator>Zou, Xuan</creator><creator>Li, Yuan</creator><creator>Chen, Cong</creator><creator>Zheng, Adi</creator><creator>Li, Hao</creator><creator>Li, Hua</creator><creator>Szeto, Ignatius Man-Yau</creator><creator>Shi, Yujie</creator><creator>Long, Jiangang</creator><creator>Liu, Jiankang</creator><creator>Feng, Zhihui</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>201402</creationdate><title>Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice</title><author>Cao, Ke ; Xu, Jie ; Zou, Xuan ; Li, Yuan ; Chen, Cong ; Zheng, Adi ; Li, Hao ; Li, Hua ; Szeto, Ignatius Man-Yau ; Shi, Yujie ; Long, Jiangang ; Liu, Jiankang ; Feng, Zhihui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Antioxidants - pharmacology</topic><topic>Apoptosis</topic><topic>Blood Glucose - metabolism</topic><topic>Diet, High-Fat</topic><topic>Dietary Fats - adverse effects</topic><topic>Dynamins - genetics</topic><topic>Dynamins - metabolism</topic><topic>fas Receptor - genetics</topic><topic>fas Receptor - metabolism</topic><topic>Free radicals</topic><topic>Gene Expression Regulation</topic><topic>Hydroxytyrosol</topic><topic>Hyperglycemia - drug therapy</topic><topic>Hyperglycemia - etiology</topic><topic>Hyperglycemia - metabolism</topic><topic>Hyperglycemia - pathology</topic><topic>Hyperlipidemias - drug therapy</topic><topic>Hyperlipidemias - etiology</topic><topic>Hyperlipidemias - metabolism</topic><topic>Hyperlipidemias - pathology</topic><topic>Insulin Resistance</topic><topic>Lipid Metabolism - drug effects</topic><topic>Male</topic><topic>Metabolic Syndrome - drug therapy</topic><topic>Metabolic Syndrome - etiology</topic><topic>Metabolic Syndrome - metabolism</topic><topic>Metabolic Syndrome - pathology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondria - pathology</topic><topic>Mitochondrial abnormalities</topic><topic>Obesity - drug therapy</topic><topic>Obesity - etiology</topic><topic>Obesity - metabolism</topic><topic>Obesity - pathology</topic><topic>Olea</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Phenylethyl Alcohol - analogs &amp; derivatives</topic><topic>Phenylethyl Alcohol - pharmacology</topic><topic>Protein Carbonylation</topic><topic>Signal Transduction</topic><topic>Sterol Regulatory Element Binding Protein 1 - genetics</topic><topic>Sterol Regulatory Element Binding Protein 1 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cao, Ke</creatorcontrib><creatorcontrib>Xu, Jie</creatorcontrib><creatorcontrib>Zou, Xuan</creatorcontrib><creatorcontrib>Li, Yuan</creatorcontrib><creatorcontrib>Chen, Cong</creatorcontrib><creatorcontrib>Zheng, Adi</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>Li, Hua</creatorcontrib><creatorcontrib>Szeto, Ignatius Man-Yau</creatorcontrib><creatorcontrib>Shi, Yujie</creatorcontrib><creatorcontrib>Long, Jiangang</creatorcontrib><creatorcontrib>Liu, Jiankang</creatorcontrib><creatorcontrib>Feng, Zhihui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Free radical biology &amp; medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cao, Ke</au><au>Xu, Jie</au><au>Zou, Xuan</au><au>Li, Yuan</au><au>Chen, Cong</au><au>Zheng, Adi</au><au>Li, Hao</au><au>Li, Hua</au><au>Szeto, Ignatius Man-Yau</au><au>Shi, Yujie</au><au>Long, Jiangang</au><au>Liu, Jiankang</au><au>Feng, Zhihui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice</atitle><jtitle>Free radical biology &amp; medicine</jtitle><addtitle>Free Radic Biol Med</addtitle><date>2014-02</date><risdate>2014</risdate><volume>67</volume><spage>396</spage><epage>407</epage><pages>396-407</pages><issn>0891-5849</issn><eissn>1873-4596</eissn><abstract>A Mediterranean diet rich in olive oil has profound influence on health outcomes including metabolic syndrome. However, the active compound and detailed mechanisms still remain unclear. Hydroxytyrosol (HT), a major polyphenolic compound in virgin olive oil, has received increased attention for its antioxidative activity and regulation of mitochondrial function. Here, we investigated whether HT is the active compound in olive oil exerting a protective effect against metabolic syndrome. In this study, we show that HT could prevent high-fat-diet (HFD)-induced obesity, hyperglycemia, hyperlipidemia, and insulin resistance in C57BL/6J mice after 17 weeks supplementation. Within liver and skeletal muscle tissues, HT could decrease HFD-induced lipid deposits through inhibition of the SREBP-1c/FAS pathway, ameliorate HFD-induced oxidative stress by enhancing antioxidant enzyme activities, normalize expression of mitochondrial complex subunits and mitochondrial fission marker Drp1, and eventually inhibit apoptosis activation. Moreover, in muscle tissue, the levels of mitochondrial carbonyl protein were decreased and mitochondrial complex activities were significantly improved by HT supplementation. In db/db mice, HT significantly decreased fasting glucose, similar to metformin. Notably, HT decreased serum lipid, at which metformin failed. Also, HT was more effective at decreasing the oxidation levels of lipids and proteins in both liver and muscle tissue. Similar to the results in the HFD model, HT decreased muscle mitochondrial carbonyl protein levels and improved mitochondrial complex activities in db/db mice. Our study links the olive oil component HT to diabetes and metabolic disease through changes that are not limited to decreases in oxidative stress, suggesting a potential pharmaceutical or clinical use of HT in metabolic syndrome treatment. •High-fat-diet (HFD)-induced metabolic syndrome was prevented by hydroxytyrosol.•Hydroxytyrosol (HT) could inhibit the SREBP-1c/FAS pathway in mouse liver and muscle.•HFD-induced oxidative stress and mitochondrial abnormalities were eliminated by HT.•HT improved lipid and glucose metabolism in db/db mice.•HT reduced oxidative damage and improved mitochondrial activity in db/db mice.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24316371</pmid><doi>10.1016/j.freeradbiomed.2013.11.029</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0891-5849
ispartof Free radical biology & medicine, 2014-02, Vol.67, p.396-407
issn 0891-5849
1873-4596
language eng
recordid cdi_proquest_miscellaneous_1687662343
source ScienceDirect Freedom Collection
subjects Animals
Antioxidants - pharmacology
Apoptosis
Blood Glucose - metabolism
Diet, High-Fat
Dietary Fats - adverse effects
Dynamins - genetics
Dynamins - metabolism
fas Receptor - genetics
fas Receptor - metabolism
Free radicals
Gene Expression Regulation
Hydroxytyrosol
Hyperglycemia - drug therapy
Hyperglycemia - etiology
Hyperglycemia - metabolism
Hyperglycemia - pathology
Hyperlipidemias - drug therapy
Hyperlipidemias - etiology
Hyperlipidemias - metabolism
Hyperlipidemias - pathology
Insulin Resistance
Lipid Metabolism - drug effects
Male
Metabolic Syndrome - drug therapy
Metabolic Syndrome - etiology
Metabolic Syndrome - metabolism
Metabolic Syndrome - pathology
Mice
Mice, Inbred C57BL
Mitochondria - drug effects
Mitochondria - metabolism
Mitochondria - pathology
Mitochondrial abnormalities
Obesity - drug therapy
Obesity - etiology
Obesity - metabolism
Obesity - pathology
Olea
Oxidative stress
Oxidative Stress - drug effects
Phenylethyl Alcohol - analogs & derivatives
Phenylethyl Alcohol - pharmacology
Protein Carbonylation
Signal Transduction
Sterol Regulatory Element Binding Protein 1 - genetics
Sterol Regulatory Element Binding Protein 1 - metabolism
title Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T14%3A08%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hydroxytyrosol%20prevents%20diet-induced%20metabolic%20syndrome%20and%20attenuates%20mitochondrial%20abnormalities%20in%20obese%20mice&rft.jtitle=Free%20radical%20biology%20&%20medicine&rft.au=Cao,%20Ke&rft.date=2014-02&rft.volume=67&rft.spage=396&rft.epage=407&rft.pages=396-407&rft.issn=0891-5849&rft.eissn=1873-4596&rft_id=info:doi/10.1016/j.freeradbiomed.2013.11.029&rft_dat=%3Cproquest_cross%3E1687662343%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1499154702&rft_id=info:pmid/24316371&rfr_iscdi=true